Stock picks from our team of market veterans.
Here are charts investors need to look at and understand what they’re saying. These charts reinforce my views on investing this year.
Can there possibly be good buying in single-digit share prices? I’ve been trawling through the ASX-listed population looking for this kind of situation, and here are two single-digit share prices that I think fit the bill
In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, says that the chart for Orica (ORI) is reflecting the potential for further upside.
For our “HOT” stock, Raymond Chan, Head of Asian Desk at Morgans explains why he says to add Macquarie Bank (MQG) to your portfolio.
The fact of biotech investing is that the share prices are at the mercy of news flow from drug trial results, partnerships with bigger companies, regulatory interactions and a wide range of other events that can point to the increased – or decreased – likelihood of the drug, medical device or diagnostic test ever reaching the market.
In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, says that based on its attractive valuation, there may be further upside in Altium (ALU) shares over the near term.
The year has started with a rush with the stock market adding over 6% in January. Our model portfolios have also enjoyed solid gains.
For our “HOT” stock, Raymond Chan, Head of Asian Desk at Morgans explains why he says to add PEXA Group (PXA) to your portfolio.
There’s no shortage of world-class innovation coming out of our neighbour across the ditch. Here are three Kiwi stocks that I think are global standouts in their fields — and each of these, for various reasons, looks to be alluringly cheap right now.
In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, says Karoon Energy (KAR)
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.